EUVIMEDEUVIMED entdecken
Crossref

Pancreatic Body and Hepatic Fat Content Predict Impaired Glucose Regulation in Women With Polycystic Ovary Syndrome

Chang Shan, Jie Yu, Yu-Chen Zhu, Jian Zhao iD, Li-Hui Wang, Yu-Shan Li, Si-Yu Lin, Wei Liu, Qing Lu iD, Tao Tao iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgaf272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Chang Shan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Liver, Pancreas, Glucose Intolerance. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, Shanghai Sailing Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Women with polycystic ovary syndrome (PCOS) are more prone to glucose metabolism abnormalities, likely due to increased visceral adiposity.

Objective

This study aimed to investigate the association of pancreatic and hepatic fat content with glucose metabolism in PCOS.

Methods

This study included 160 women with PCOS. All participants underwent an oral glucose tolerance test. Magnetic resonance imaging–derived proton density fat fraction was used to measure fat content in different visceral organs.

Results

Pancreatic interlobular fat volume, pancreatic body fat, and hepatic fat were significantly higher in PCOS patients with diabetes than in those with normal glucose tolerance (P < .05). Elevated pancreatic body fat (OR 2.21 [95% CI 1.01-4.85], P = .047) and hepatic average fat (OR 2.92 [95% CI 1.13-7.51], P = .026) were independently associated with higher impaired glucose regulation (IGR) risks. Only patients with elevated levels of both pancreatic body fat and hepatic average fat exhibited increased risk of IGR after multiple confounding adjustments (OR 5.49 [95% CI 1.63-18.47], P = .006). The hepatic average fat to pancreatic body fat ratio lost its significant association with IGR risk after multivariable adjustment (P = .705). The combination of pancreatic body fat and hepatic average fat with traditional risk factors (age, body mass index, waist to hip circumference ratio, serum triglycerides, and free androgen index) demonstrated a trend toward improved predictive performance for IGR, with the highest area under the curve (0.789) observed.

Conclusion

Pancreatic body and hepatic fat content predict IGR and synergistically regulate glucose metabolism in PCOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeLiverPancreasGlucose IntoleranceAdipose TissueHumansFemaleAdultGlucose Tolerance TestYoung AdultMagnetic Resonance ImagingBlood GlucoseAdiposityIntra-Abdominal Fat

Stichwörter der Autor:innen

fat content (proton density fat fraction)impaired glucose regulationmagnetic resonance imagingpancreatic bodypolycystic ovary syndrome

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
  • Ministry of Education and Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
  • Department of Maternal and Child Health, School of Public Health, Shanghai Jiao Tong University, Shanghai 200092, China.
  • School of Public Health and Emergency Management, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China.
  • Department of Radiology, Shanghai East Hospital, Tongji University, Shanghai 200123, China.

ORCID-Profile: Jian Zhao, Qing Lu, Tao Tao

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai
  • Shanghai Sailing Program
  • National Nature Promotion Project
  • Ren Ji Hospital
  • Shanghai Jiao Tong University School of Medicine
  • Bethune Charitable Foundation
  • Shanghai Medical and Health Development Foundation

Zitieren

APA

Shan, C., Yu, J., Zhu, Y. C., Zhao, J., Wang, L. H., Li, Y. S., Lin, S. Y., Liu, W., Lu, Q., & Tao, T. (2025). Pancreatic Body and Hepatic Fat Content Predict Impaired Glucose Regulation in Women With Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf272

Vancouver

Shan C, Yu J, Zhu YC, Zhao J, Wang LH, Li YS, et al. Pancreatic Body and Hepatic Fat Content Predict Impaired Glucose Regulation in Women With Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf272

BibTeX
@article{Shan2025,
  author = {Shan, Chang and Yu, Jie and Zhu, Yu-Chen and Zhao, Jian and Wang, Li-Hui and Li, Yu-Shan and Lin, Si-Yu and Liu, Wei and Lu, Qing and Tao, Tao},
  title = {Pancreatic Body and Hepatic Fat Content Predict Impaired Glucose Regulation in Women With Polycystic Ovary Syndrome},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgaf272}
}
Kostenlos starten →